177 related articles for article (PubMed ID: 36139501)
21. Role of adipose tissue-derived cytokines in the progression of inflammatory breast cancer in patients with obesity.
Ibrahim AS; El-Shinawi M; Sabet S; Ibrahim SA; Mohamed MM
Lipids Health Dis; 2022 Aug; 21(1):67. PubMed ID: 35927653
[TBL] [Abstract][Full Text] [Related]
22. Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.
Eustace NJ; Anderson JC; Langford CP; Trummell HQ; Hicks PH; Jarboe JS; Mobley JA; Hjelmeland AB; Hackney JR; Pedersen RT; Cosby K; Gillespie GY; Bonner JA; Willey CD
Int J Oncol; 2019 Jun; 54(6):2039-2053. PubMed ID: 30942445
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.
Jansen MP; Sas L; Sieuwerts AM; Van Cauwenberghe C; Ramirez-Ardila D; Look M; Ruigrok-Ritstier K; Finetti P; Bertucci F; Timmermans MM; van Deurzen CH; Martens JW; Simon I; Roepman P; Linn SC; van Dam P; Kok M; Lardon F; Vermeulen PB; Foekens JA; Dirix L; Berns EM; Van Laere S
Mol Oncol; 2015 Jun; 9(6):1218-33. PubMed ID: 25771305
[TBL] [Abstract][Full Text] [Related]
24. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase.
Lehman HL; Van Laere SJ; van Golen CM; Vermeulen PB; Dirix LY; van Golen KL
Mol Cancer Res; 2012 Oct; 10(10):1306-18. PubMed ID: 22896661
[TBL] [Abstract][Full Text] [Related]
25. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
[TBL] [Abstract][Full Text] [Related]
26. Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.
Zoratti GL; Tanabe LM; Hyland TE; Duhaime MJ; Colombo É; Leduc R; Marsault E; Johnson MD; Lin CY; Boerner J; Lang JE; List K
Oncotarget; 2016 Sep; 7(36):58162-58173. PubMed ID: 27528224
[TBL] [Abstract][Full Text] [Related]
27. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer.
Van Laere S; Beissbarth T; Van der Auwera I; Van den Eynden G; Trinh XB; Elst H; Van Hummelen P; van Dam P; Van Marck E; Vermeulen P; Dirix L
Clin Cancer Res; 2008 Nov; 14(22):7452-60. PubMed ID: 19010862
[TBL] [Abstract][Full Text] [Related]
28. Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors.
Santiago-Sánchez GS; Noriega-Rivera R; Hernández-O'Farrill E; Valiyeva F; Quiñones-Diaz B; Villodre ES; Debeb BG; Rosado-Albacarys A; Vivas-Mejía PE
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445288
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival.
Bickeböller M; Tagscherer KE; Kloor M; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Toth C; Schirmacher P; Roth W; Bläker H
Oncogene; 2015 Feb; 34(9):1150-9. PubMed ID: 24662837
[TBL] [Abstract][Full Text] [Related]
30. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.
Remo A; Simeone I; Pancione M; Parcesepe P; Finetti P; Cerulo L; Bensmail H; Birnbaum D; Van Laere SJ; Colantuoni V; Bonetti F; Bertucci F; Manfrin E; Ceccarelli M
J Transl Med; 2015 May; 13():138. PubMed ID: 25928084
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion.
Victor BC; Anbalagan A; Mohamed MM; Sloane BF; Cavallo-Medved D
Breast Cancer Res; 2011; 13(6):R115. PubMed ID: 22093547
[TBL] [Abstract][Full Text] [Related]
32. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
34. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.
Allen SG; Chen YC; Madden JM; Fournier CL; Altemus MA; Hiziroglu AB; Cheng YH; Wu ZF; Bao L; Yates JA; Yoon E; Merajver SD
Sci Rep; 2016 Dec; 6():39190. PubMed ID: 27991524
[TBL] [Abstract][Full Text] [Related]
35. Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets.
Van Laere SJ; Ueno NT; Finetti P; Vermeulen P; Lucci A; Robertson FM; Marsan M; Iwamoto T; Krishnamurthy S; Masuda H; van Dam P; Woodward WA; Viens P; Cristofanilli M; Birnbaum D; Dirix L; Reuben JM; Bertucci F
Clin Cancer Res; 2013 Sep; 19(17):4685-96. PubMed ID: 23396049
[TBL] [Abstract][Full Text] [Related]
36. EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.
Mu Z; Li H; Fernandez SV; Alpaugh KR; Zhang R; Cristofanilli M
J Exp Clin Cancer Res; 2013 Sep; 32(1):70. PubMed ID: 24294976
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
Song YH; Zhang CQ; Chen FF; Lin XY
Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
[TBL] [Abstract][Full Text] [Related]
38. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
[No Abstract] [Full Text] [Related]
39. MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer.
Liu J; Chen SJ; Hsu SW; Zhang J; Li JM; Yang DC; Gu S; Pinkerton KE; Chen CH
Theranostics; 2021; 11(9):4122-4136. PubMed ID: 33754052
[No Abstract] [Full Text] [Related]
40. Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signaling.
Ohshiro K; Schwartz AM; Levine PH; Kumar R
PLoS One; 2012; 7(1):e30725. PubMed ID: 22295107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
